Journal
DRUG DISCOVERY TODAY
Volume 11, Issue 11-12, Pages 541-549Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2006.04.007
Keywords
-
Categories
Funding
- MRC [G9811527] Funding Source: UKRI
- Medical Research Council [G9811527] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
Ask authors/readers for more resources
The growing recognition that members of the rhodopsin-like family A G-protein-coupled receptors (GPCRs) exist and function as dimers or higher-order oligomers, and that GPCR hetero-dimers and oligomers are present in physiological tissues, offers novel opportunities for drug discovery. Differential pharmacology, function and regulation of GPCR hetero-dimers and -oligomers suggest means to selectively target GPCRs in different tissues and hint that the mechanism of function of several pharmacological agents might be different in vivo than anticipated from simple ligand-screening programmes that rely on heterologous expression of a single GPCR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available